Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Distributed under the brand names Geref and Geref Diagnostic, it gained FDA approval in 1997 as a treatment for growth hormone deficiency but was discontinued in 2008 not out of concern for safety or lack of efficacy, but because of manufacturing difficulties.2 3 Yet it remains available in compounded form with a prescription from a licensed healthcare provider
This regulatory position means that BPC-157 sold by U.S
Allspring Funds Management acts as a discretionary manager for separately managed accounts ("SMA") and as a non-discretionary model provider in a variety of managed account or wrap fee programs (MA Programs) sponsored by third party investment advisers, broker-dealers, or other financial services firms (a Sponsor)
A peptide derived from Body Protection Compound (BPC), originally identified in gastric juice
US$ 23.04
US$ 20.52
US$ 22.23
US$ 20.55
US$ 21.82